mTOR was also recently shown to activate S-adenosylmethionine decarboxylase proenzyme (AMD1), which phosphorylates obesity-associated protein (FTO) and subsequently increases the expression of a number of transcription factors that participate in cancer genesis, progression, and stemness (98, 117). The gene discussed is AMD1; the disease is cancer.